Achilles Tendinopathy
Achilles Tendinopathy is a condition that affects the Achilles tendon, causing pain and stiffness in the back of the heel and lower leg, often due to overuse or injury.
Achilles Tendinopathy: NGI226 Microparticles Study
We are investigating the safety and effects of NGI226 microparticles for patients with Achilles tendinopathy. This study aims to see if it helps restore tendon strength compared to a placebo.
6-12 months>20 visitsEfficacy phase (II)Investigational MedicinesInjectionInternal MedicineOrthopedics and Traumatology
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you between 30 and 70 years old?
- Do you have pain in your Achilles tendon during activities like walking or running?
- Have you had this Achilles tendon pain for at least 8 weeks but less than 12 months?
- Have you tried conservative treatments like physiotherapy or rest for at least 6 weeks without improvement?
- Are you currently taking blood thinners like Warfarin, Eliquis, or Xarelto?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Ngi226
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Ass Hospitaliere Protestante De Lyon
2000: Rhumatology
Caluire-et-Cuire, France
Hospital Hotel Dieu
2001: Rhumatology
Nantes, France
Charite Research Organisation GmbH
1003
Berlin, Germany
Sponsor: Novartis Pharma AG
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.